Methylphenidate HCL IR

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D224R0007

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
The Defense Logistics Agency (DLA) Troop Support has issued a solicitation, identified by procurement number SPE2D224R0007, for the supply of Methylphenidate HCL IR (Immediate Release). This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code (PSC) 6505, indicating a focus on drugs and biologicals. The primary objective of this solicitation is to secure a reliable source of Methylphenidate HCL IR to support the medical and pharmaceutical needs of federal agencies, likely including military and other government healthcare facilities. The scope of the procurement encompasses the manufacturing and timely delivery of this pharmaceutical product in accordance with federal standards and specifications. The intended outcome is to ensure an uninterrupted supply chain for this critical medication, supporting the health and readiness of personnel served by DLA Troop Support. Key requirements for prospective contractors include demonstrated capability in pharmaceutical preparation manufacturing, compliance with all applicable regulatory standards, and the ability to meet the quality and delivery expectations set forth by DLA Troop Support. While the specific quantities, packaging, and delivery schedules are not detailed in the provided notice, contractors should anticipate the need to adhere to stringent federal guidelines and provide documentation as required by the solicitation and any subsequent amendments. Amendment 0001 has been issued and is attached to the solicitation, indicating that interested parties should review all current documents to ensure compliance with the latest requirements. The contracting entity for this opportunity is DLA Troop Support, a federal office responsible for the procurement and supply of a wide range of products and services to support the U.S. military and other federal agencies. The primary points of contact for this solicitation are Nancy Fernandez ([email protected], 215-737-4955) and Catherine Gilbert ([email protected], 215-737-4778), who can provide further information and clarification regarding the solicitation process. This is an active solicitation, with a response due date of May 8, 2024. Interested contractors are encouraged to review the full solicitation and all attachments, available through the official SAM.gov opportunity page (https://sam.gov/opp/7ebf00c7fc3f45ca9cf313ab95481c35/view), to ensure a comprehensive understanding of the requirements and submission procedures. The notice does not specify any set-aside requirements or special considerations such as small business preferences; therefore, all qualified manufacturers are invited to respond. In summary, this procurement represents an opportunity for pharmaceutical manufacturers with the requisite capabilities and compliance history to supply Methylphenidate HCL IR to the federal government, supporting critical healthcare operations. Contractors should ensure they meet all regulatory and contractual obligations and submit their proposals by the stated deadline to be considered for award.